Natera saw the highest growth of 124% in patent filings in October and 99% in grants in November in Q4 2023. Compared to Q3 2023, Q4 2023 saw an increase in patent filings by 124% and grants by 49%. GlobalData’s DataBook provides a comprehensive analysis of Natera‘s patent filings and grants. Buy the databook here.
Natera has been focused on protecting inventions in United States(US) with six publications in Q4 2023
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 0% grants. The United States(US), Brazil(BR), World Intellectual Property Organization(WIPO), and China(CN) patent Office are among the top ten patent offices where Natera is filings its patents. Among the top granted patent authorities, Natera has 100% of its grants in China(CN)
Patents related to genomics and healthtech lead Natera's portfolio
Natera has the highest number of patents in genomics followed by, healthtech and machine learning. For genomics, nearly 75% of patents were filed and 100% of patents were granted in Q4 2023.
Solid tumor related patents lead Natera portfolio
Natera has highest number of patents in solid tumor.
For comprehensive analysis of Natera's filings and grants, buy the databook here.
Premium Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.